In conclusion, owing to Lys199 and His242 of HSA replacing with leaving groups of Cu pro-drug and coordinating with Cu2+, the delivery efficiency and anticancer activity of Cu compound has been improved through tighter binding to the IIA subdomain of HSA, and by selectively accumulating in tumor tissue. Here, ALB is linked to neoplasm.